# Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

Federal grant opportunity, via Kontrakk.

- **Agency:** National Institutes of Health
- **Opportunity number:** PAR-25-096
- **Status:** posted
- **Opens:** November 18, 2024
- **Closes:** November 17, 2026
- **CFDA:** 93.393, 93.121, 93.172, 93.866
- **View on Kontrakk:** https://kontrakk.com/grants/357205

## Description

No description provided.